64P Assessment of clinical benefit of cancer drugs recommended in National Comprehensive Cancer Centre (NCCN) guidelines for advanced gastrointestinal stromal tumors (GIST)

Lleida, R. Teres ; Sorolla, M. Aguado ; Cardozo, A. Romano ; Bosma, F. ; Del Rio, S. Sanchez ; Piedra, A. ; Tibau, A. ; Garcia, A. Sebio

ESMO open, 2024-03, Vol.9, p.102454, Article 102454 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível